Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 49 out of 100. Getting a diagnosis

Topic: Risk, prevention and care in population studies

Plain-language summary

The proportion of false negatives from FDG-PET ranged from 11-55%. The lowest proportion of false negatives was found in the Frontotemporal dementia diagnosis group, and the highest proportion of false negatives was found in the other neurodegeneration group. In early-onset dementia patients (N = 112), the proportion of false negatives ranged from 15-60%. FDG-PET-CT of the brain produces a notable proportion of false negatives in dementia workups, suggesting limitations in sensitivity. These findings indicate that FDG-PET-CT alone may not be sufficiently reliable for diagnostic use in clinical practice and should be complemented by additional diagnostic methods.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 112 participants. This study found that FDG-PET-CT produced a notable proportion of false negatives in dementia workups, ranging from 11-55% overall and 15-60% in early-onset patients. The authors conclude it may not be sufficiently reliable alone and should be complemented by other diagnostic methods; it concerns diagnosis, not treatment or cure.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Shoebridge, A., Shao, B., Lee, A. R., Sargisson, H., Mukaetova‐Ladinska, E. B., & Hosseini, A. A. (2025). Diagnostic Accuracy of FDG‐PET‐CT in Dementia: Assessing False Negatives in Clinical Practice. Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_107434

Vancouver

Shoebridge A, Shao B, Lee AR, Sargisson H, Mukaetova‐Ladinska EB, Hosseini AA. Diagnostic Accuracy of FDG‐PET‐CT in Dementia: Assessing False Negatives in Clinical Practice. Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_107434. PMID: 41511465.

BibTeX

@article{shoebridge2025-41511465,
  author  = {Shoebridge, Autumn and Shao, Beili and Lee, Abigail Rebecca and Sargisson, Hannah and Mukaetova‐Ladinska, Elizabeta B. and Hosseini, Akram A.},
  title   = {{Diagnostic Accuracy of FDG‐PET‐CT in Dementia: Assessing False Negatives in Clinical Practice}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_107434},
  pmid    = {41511465},
  url     = {https://doi.org/10.1002/alz70856_107434}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that FDG-PET-CT produced a notable proportion of false negatives in dementia workups, ranging from 11-55% overall and 15-60% in early-onset patients. The authors conclude it may not be sufficiently reliable alone and should be complemented by other diagnostic methods; it concerns diagnosis, not treatment or cure.

Study details

How this study scored 49/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 49 of 100.49 of 100 points earned51 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 112 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Akram A. Hosseini: h-index 22 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Nottingham: institution h-index 879 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41511465)
Free to read 2 / 2 Free to read
Total 49 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Getting a diagnosis from nearby years

Also tagged “machine”

834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →